Skip to content
Screener

Other, net at other companies

Abbott logo
AbbottABT
-$20.5M
Tenet Healthcare logo
Tenet HealthcareTHC
-$77M-97.4%
Pfizer logo
PfizerPFE
-$284M+20.2%
Stryker logo
StrykerSYK
-$147M-2,350%
Boston Scientific logo
Boston ScientificBSX
$3M+130%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$2.3M-156%

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$619.3B+50.7%
Enterprise value$647.91B+46.2%
P/E29.4×+11.3×
P/S6.3×+1.8×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: Johnson & Johnson’s 10-Q, filed April 22, 2026.

Filed
Apr 22, 2026, 4:02 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000200406-26-000087
Line itemFiscal Three Months Ended / March 29,2026Fiscal Three Months Ended / March 30,2025
Repayment of long-term debt(2,002)(751)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net1,172450
Credit support agreements activity, net(109)(3)
Other(588)40
Net cash from financing activities53010,422
Effect of exchange rate changes on cash and cash equivalents(25)70
Increase in cash and cash equivalents1,97914,369
Cash and cash equivalents, beginning of period19,70924,105

Item 1 — Financial statements

FAQ

What is Johnson & Johnson's other, net?
Johnson & Johnson (JNJ) reported other, net of -$588M in Q1 2026.
How has Johnson & Johnson's other, net changed year-over-year?
Johnson & Johnson's other, net decreased by 1570.0% year-over-year, from $40M to -$588M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about Johnson & Johnson's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude